ShareValue scores for HMD.AU: Valuation 50, Quality 29, Growth 42, Health 45.

Heramed Ltd logo

HMD.AU
ASX

Heramed Ltd

A$0.03(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 17%
Valuation
50
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
42
Moderate
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
50
Neutral
Price Trend

Company Details

About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026